CIPLABSECipla Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 20 Feb, 2026 · 17:57 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

Creeping Acquisition Near ThresholdOwnership Changes View source PDFExplain this filing

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.8%Reaction day
₹1338.00
prior close
₹1335.90
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.5%-1.3% vs market
Pharmaceuticals peers, median of 155sector-0.2%-0.7% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty 100 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.7
10m
-1.7
15m
-1.1
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.8+0.5-1.3-0.2-0.7
Next day
-0.6-0.4-0.2-0.9+0.3
2d
+0.5-0.1+0.6-0.7+1.2
3d
+1.5+0.0+1.5-0.4+1.9
4d
+0.6-1.2+1.8-1.7+2.3
5d
+1.0-2.5+3.5-3.4+4.4
1w
-0.8-3.0+2.3-3.1+2.3
15d
-4.3-7.6+3.2-5.4+1.1
1m
-8.8-11.9+3.1-8.5-0.3
2m
-2.3-4.3+2.0+3.3-5.7
3m
+5.6-4.6+10.2+7.5-1.9
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Life Insurance Corporation of India (LIC) has disclosed purchase of 1.64 crore additional shares (2.036%) of Cipla through open market transactions between 27 November 2025 and 18 February 2026. LIC is not part of the promoter group. Before this acquisition LIC held 5.69 crore shares (7.055%) and after the purchase its holding stands at 7.34 crore shares, equal to 9.091% of Cipla's equity capital. The acquisition was carried out via market purchases and the filing is under SEBI's SAST Regulation 29(2) which applies to shareholders holding more than 5%.

Likely market impact

This is a meaningful institutional accumulation by a major domestic insurer, pushing LIC close to the 10% disclosure threshold — a near-2% stake addition over roughly three months signals strong conviction in Cipla and may support sentiment around the stock.